Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Novacyt S.A.

Start price
Target price
Perf. (%)
€3.70
31.05.20
€5.00
04.11.21
-12.32%
04.10.21

Could be worthwhile Investment >10% per year
Innate Pharma

Start price
Target price
Perf. (%)
€6.61
18.09.21
€3.00
18.09.22
-22.01%
02.10.21

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
buy
Valbiotis

Start price
Target price
Perf. (%)
€8.00
19.07.20
€7.50
04.11.21
-11.88%
26.09.21

Could be worthwhile Investment >10% per year
buy
Inventiva SA

Start price
Target price
Perf. (%)
€3.33
10.09.21
€12.00
-
10.09.21

Could be worthwhile Investment >10% per year
Inventiva SA

Start price
Target price
Perf. (%)
€3.33
10.09.21
€8.00
-
10.09.21

Could be worthwhile Investment >10% per year
Innate Pharma

Start price
Target price
Perf. (%)
€6.20
03.09.21
-
03.09.22
-25.29%
06.09.21

Risky Investment
Advicenne

Start price
Target price
Perf. (%)
€2.20
31.08.21
€10.00
30.05.22
-
31.08.21

Could be worthwhile Investment >10% per year
buy
Advicenne

Start price
Target price
Perf. (%)
€8.74
30.05.21
€10.00
30.05.22
-10.98%
31.08.21

Could be worthwhile Investment >10% per year
Erytech Pharma S.A.

Start price
Target price
Perf. (%)
€5.10
30.07.21
-
30.07.22
2.55%
08.08.21

Risky Investment
Valneva SE

Start price
Target price
Perf. (%)
€10.89
17.06.21
€8.00
17.06.22
3.21%
20.07.21

Could be worthwhile Investment >10% per year
Very valuable balance sheet
buy
Onxeo S.A.

Start price
Target price
Perf. (%)
€0.58
16.04.20
€3.00
04.11.21
4.97%
09.07.21

buy
Guerbet S.A.

Start price
Target price
Perf. (%)
€49.95
18.03.19
€65.00
04.11.21
-39.94%
01.07.21

buy
Valneva SE

Start price
Target price
Perf. (%)
€2.10
16.03.20
€3.00
04.11.21
418.57%
17.06.21

Could be worthwhile Investment >10% per year
Very valuable balance sheet
buy
Advicenne

Start price
Target price
Perf. (%)
€13.60
14.02.21
€14.00
14.02.22
-35.74%
30.05.21

Could be worthwhile Investment >10% per year
buy
DBV Technologies S.A.

Start price
Target price
Perf. (%)
€3.45
03.11.20
-
04.11.21
136.51%
15.01.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Adocia

Start price
Target price
Perf. (%)
€18.50
05.08.19
€30.00
04.11.21
-59.73%
22.11.20

buy
Innate Pharma

Start price
Target price
Perf. (%)
€6.26
26.07.19
€30.00
04.11.21
-32.24%
22.11.20

Novacyt S.A.

Start price
Target price
Perf. (%)
€10.10
19.10.20
€4.00
30.10.20
14.26%
30.10.20

Probably not worthwhile Investment
buy
Biom Up SA

Start price
Target price
Perf. (%)
?2.38
13.05.19
€3.90
04.11.19
0.00%
04.11.19

buy
Adocia

Start price
Target price
Perf. (%)
€13.34
03.02.19
€30.00
05.08.19
27.59%
05.08.19

buy
Innate Pharma

Start price
Target price
Perf. (%)
€5.92
26.07.19
€15.00
30.07.19
0.00%
30.07.19

buy
Orpea Nom.

Start price
Target price
Perf. (%)
€103.90
17.03.19
€110.00
30.07.19
8.18%
30.07.19

Could be worthwhile Investment >10% per year
buy
Sartorius Stedim Biotech S.A.

Start price
Target price
Perf. (%)
€120.90
04.05.19
€130.00
12.06.19
8.11%
12.06.19

Could be worthwhile Investment >10% per year
buy
Novacyt S.A.

Start price
Target price
Perf. (%)
€0.39
22.08.18
€0.60
24.04.19
-50.77%
24.04.19

Could be worthwhile Investment >10% per year
buy
Amplitude Surgical SAS

Start price
Target price
Perf. (%)
€3.34
26.01.19
€3.60
24.04.19
-19.76%
24.04.19